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investigates the possibility to use oxygen beams for hadron therapy, as an alternative to carbon ions.
Materials and Methods: Oxygen ions have the advantage of a higher relative biological effectiveness
(RBE) and better conformality to the tumor target. This work describes the mixed radiation field produced
by an oxygen beam in water and compares it to the one produced by a therapeutic carbon ion beam. The
study has been performed using Geant4 simulations. The dose is calculated for incident carbon ions with
energies of 162 MeV/u and 290 MeV/u, and oxygen ions with energies of 192 MeV/u and 245 MeV/u, and
hence that the range of the primary oxygen ions projectiles in water was located at the same depth as the
carbon ions. Results: The results show that the benefits of oxygen ions are more pronounced when using
lower energies because of a slightly higher peak-to-entrance ratio, which allows either providing higher
dose in tumor target or reducing it in the surrounding healthy tissues. It is observed that, per incident
particle, oxygen ions deliver higher doses than carbon ions.Conclusions: This result coupled with the
higher RBE shows that it may be possible to use a lower fluence of oxygen ions to achieve the same
therapeutic dose in the patient as that obtained with carbon ion therapy.

Disciplines
Engineering | Science and Technology Studies

Publication Details
Ying, C., Bolst, D., Rozenfeld, A. & Guatelli, S. (2019). Characterization of the mixed radiation field
produced by carbon and oxygen ion beams of therapeutic energy: A Monte Carlo simulation study.
Journal of Medical Physics, 44 (4), 263-269.

This journal article is available at Research Online: https://ro.uow.edu.au/eispapers1/3548

1/23/2020

Characterization of the mixed radiation field produced by carbon and oxygen ion beams of therapeutic energy: A Monte Carlo simula…

ORIGINAL ARTICLE
Year : 2019 | Volume : 44 | Issue : 4 | Page : 263--269

Characterization of the mixed radiation field produced by carbon and oxygen ion beams of therapeutic energy: A Monte
Carlo simulation study
CK Ying1, David Bolst2, Anatoly Rosenfeld2, Susanna Guatelli2,
1 Oncological and Radiological Science Cluster, Advanced Medical and Dental Institute, Universiti Sains Malaysia, Kepala Batas, Pulau Pinang, Malaysia
2 Centre of Medical Radiation Physics, University of Wollongong, NSW, Australia
Correspondence Address:
Dr. C K Ying
Oncological and Radiological Science Cluster, Advanced Medical and Dental Institute, Universiti Sains Malaysia, 13200, Kepala Batas, Pulau Pinang
Malaysia

Abstract
Purpose: The main advantages of charged particle radiotherapy compared to conventional X-ray external beam radiotherapy are a better tumor conformality coupled with the capability
of treating deep-seated radio-resistant tumors. This work investigates the possibility to use oxygen beams for hadron therapy, as an alternative to carbon ions. Materials and Methods:
Oxygen ions have the advantage of a higher relative biological effectiveness (RBE) and better conformality to the tumor target. This work describes the mixed radiation field produced by
an oxygen beam in water and compares it to the one produced by a therapeutic carbon ion beam. The study has been performed using Geant4 simulations. The dose is calculated for
incident carbon ions with energies of 162 MeV/u and 290 MeV/u, and oxygen ions with energies of 192 MeV/u and 245 MeV/u, and hence that the range of the primary oxygen ions
projectiles in water was located at the same depth as the carbon ions. Results: The results show that the benefits of oxygen ions are more pronounced when using lower energies
because of a slightly higher peak-to-entrance ratio, which allows either providing higher dose in tumor target or reducing it in the surrounding healthy tissues. It is observed that, per
incident particle, oxygen ions deliver higher doses than carbon ions.Conclusions: This result coupled with the higher RBE shows that it may be possible to use a lower fluence of
oxygen ions to achieve the same therapeutic dose in the patient as that obtained with carbon ion therapy.
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Full Text
Introduction

Proton and carbon ion therapy are two types of hadron therapy which have been increasingly used in recent years for cancer treatment, with many new facilities under construction or
planned for the near future.[1],[2],[3],[4],[5],[6] One of the main advantages of charged particle radiotherapy compared to conventional X-ray external beam radiotherapy is a better dose
conformality. Heavy charged particles deposit the major part of their energy at the end of their range, at the Bragg peak. This allows to provide greater dose in the tumor while sparing the
surrounding healthy tissues. For this reason, hadron therapy is particularly suitable for deep-seated tumors.[7],[8]
Currently, hadron therapy centers in the United States offer only proton beams.[9] Carbon ion therapy is currently available in Japan, for example, at the heavy-ion medical accelerator
(HIMAC) at the National Institute of Radiological Sciences (NIRS, Chiba), and in Europe, for example, the Heidelberg Ion-Beam Therapy Center (HIT).
Oxygen ions are currently considered as a potential alternative to carbon ions. Because of their mass, oxygen ions have less lateral scattering. This contributes favorably to the tumor
conformality. The high linear energy transfer (LET) of oxygen ions when compared to carbon ions is associated with higher radiobiological effectiveness (RBE) which translates to better
treatment effectiveness when treating hypoxic tumors.[10],[11],[12] Kurz et al. published the results of the first experimental-based study of an oxygen ion beam in 2012. In particular,
they measured the depth-dose distributions of oxygen ions beams at the HIT. Their work contributed to the development of a preclinical oxygen ion-beam experimental database, already
being used in research purpose treatment planning systems to support radiobiological experiments with oxygen ion beams at HIT.[13] With respect to carbon ions, oxygen ions produce
more nuclear fragments, which need to be investigated, as they can affect the RBE and the sensitivity to oxygenation.[14] In addition, the dose due to such fragments needs to be
investigated not only in-field but also out-of-field, laterally and beyond the Bragg peak, to study the effect of the mixed radiation field in the healthy tissues surrounding the tumor target.
The possible use of helium and oxygen ions in hadron therapy has recently gained more attention. Yu-Shen et al. investigated the longitudinal and lateral dose profiles and RBE
produced by protons, α particles, and carbon ions.[15] Tessonnier et al. studied the basic dosimetric features of the different ions, including oxygen ions by experiments.[16] Mattei et al.
studied the prompt gamma-ray emission by the interaction of helium, carbon, and oxygen ion beams with a polymethyl methacrylate phantom.[17] Burigo et al. compared the dose
distributions and cell survival fractions for various incident ions. They concluded that the optimal projectile depends on the location of the tumor and on the radiosensitivity of the
irradiated tissues.[18]
This work compares the dose produced in a water phantom by an oxygen ion (16 O) beam with respect to a carbon (12 C) ion beam. This work has been done by using Geant4 Monte
Carlo simulations.[19]

Materials and Methods

Geant4 Monte Carlo simulation toolkit, from the European Organization for Nuclear Research, CERN (Geneva, Switzerland) version 4.10.1.p01 was used to model and compare the
radiation fields produced by carbon and oxygen ion beams in a 30 cm × 30 cm × 30 cm water phantom. A 5 cm × 5 cm square beam is simulated normally incident on the water phantom
with an air gap of 30 cm between the particle source and the surface of the phantom. Carbon beams were generated with energies of 162 MeV/u and 290 MeV/u, which are typical
energies used in carbon ion therapy at HIMAC.[20] The simulations were repeated substituting the carbon with an oxygen beam with energies 192 MeV/u and 345 MeV/u (corresponding
to ranges of approximately 60 mm and 161 mm in water, similar to the carbon ion beam).
The G4EmStandardPhysics_Option3 and QGSP_BIC_EMY Geant4 Physics List were adopted to model the electromagnetic and hadronic physics interactions.[21] The results obtained
with oxygen and carbon ion beams were compared in terms of dose distribution in the phantom and peak to entrance dose ratio. The contribution to dose deriving from secondary
fragments was studied as well. 106 histories were simulated for each configuration to obtain a statistical uncertainty within 1%, with the corresponding confidence interval of the
uncertainty being 95%.
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Results and Discussion

[Figure 1] shows the energy deposited in the phantom per incident particle in the case of incident 162 MeV/u 12 C and 192 MeV/u 16 O ions. The 16 O beam produces approximately
50% higher energy deposition than the 12 C beam at the entrance, at 2 mm depth from the surface of the phantom. At the Bragg peak, approximately at 60-mm depth from the surface of
the phantom, the 16 O beam produces approximately 60% higher energy deposition than the 12 C beam. In addition, the 16 O beam produces 150% higher energy deposition tail just
after the Bragg peak (at 2-mm depth after the Bragg peak). The peak-to-entrance ratio is 9.0 for the 16 O, just slightly higher than that of 12 C beams, which is 8.5.{Figure 1}
[Figure 2] shows the energy deposition per incident particle, for 12 C and 16 O beams with energies 290 MeV/u and 345 MeV/u, respectively. In this case, it was found that the dose at
the entrance (at 2-mm depth from the surface of the phantom) and at the Bragg peak (approximately at 60-mm depth), produced by the 16 O ions was about 60% higher than in the case
of the 12 C beam. Still, the dose at the distal edge of the Bragg peak (2 mm after the Bragg peak) is 140% higher in the case of irradiation with oxygen beams. This is a shortcoming of
oxygen ions (organs at risk may be located at the distal edge) and should be taken into consideration if switching from carbon ions to oxygen ions in hadron therapy. The peak-toentrance ratio for 16 O and 12 C beams is found to be 5.4 and 5.8, respectively{Figure 2}
These results are in agreement with Francesco etal., who compared absolute dose per unit fluence produced by four different types of ion species (protons and helium, carbon and
oxygen ions).[12] Higher peak-to-entrance ratio means that the dose may be increased in the tumor target or reduced in the surrounding healthy tissues of the patient, in front of the
tumor. Results of the current study show that increasing the beam energy decreases the peak-to-entrance ratio for both oxygen and carbon ions. In terms of peak-to-entrance ratio, the
benefits of oxygen ions are more pronounced at lower energy.
[Figure 3] shows the energy deposited by the secondary radiation field produced by the incident carbon ions (162 MeV/u) and oxygen ions (192 MeV/u) along the depth in the phantom.
The results are normalized per incident primary. The results clearly illustrate that fragmentation has a more prominent role in the case of the oxygen beam, as expected, in all regions
(i.e., the plateau region, the Bragg peak position, and beyond the Bragg peak). The dose contribution of individual secondary fragment species with higher production yield is presented
in [Figure 4]. Both hydrogen and helium fragments have a longer range than incident ions and heavier fragments, and they contribute most to the dose beyond the Bragg peak.{Figure 3}
{Figure 4}
It can be observed that secondary protons, produced by incident oxygen ion beams deposit more energy than in the case of carbon ions beams in all regions (i.e., the plateau region, the
Bragg peak position, and beyond the Bragg peak position). The contribution to the energy deposition deriving from secondary alpha particles is similar along the Bragg peak when
comparing oxygen and carbon ion beams. After the Bragg peak, in the case of oxygen ions, alpha particles deposit more energy.
In the case of carbon ion beams, secondary lithium (Li), beryllium (Be), and boron (B) fragments produce more dose in the plateau region and at the Bragg peak position compared to
oxygen ions, but, after the Bragg peak, the dose contribution of such fragments is higher with incident oxygen ions. The energy deposition contribution of secondary nitrogen (N)
fragments produced by primary oxygen ions is dominant everywhere along the Bragg peak.
Lateral dose distributions for several selected secondary fragments produced by incident oxygen and carbon ions have been compared. [Figure 5] shows the results for protons (P) and
helium (He), lithium (Li) and boron (B) ion fragments produced by incident 162 MeV/u 12 C and 192 MeV/u 16 O ions. The two-dimensional histogram (normalized per incident primary
particle) shows the effects of the scattering outside the radiation field. As expected, the secondary protons scatter more with respect to the other fragments because of their smaller
mass. Therefore, lighter fragments contribute more to energy deposition out-of-field. With an increase in the mass of the fragment, the energy is deposited more in a forward direction.
{Figure 5}
[Figure 6], [Figure 7], [Figure 8], [Figure 9] show the lateral distribution of the energy deposition per incident oxygen and carbon ion with energy 192 and 162 MeV/u, respectively,
including the contributions deriving from secondary protons (P) and lithium ions (Li). Li-ions have been chosen as example of heavier fragment. The comparisons have been done at
different depths in the phantom as detailed in the caption of the figures. The plots are normalized per incident primary. The bottom plots indicate the ratio of the dose calculated with
incident 16 O and 12 C beams.{Figure 6}{Figure 7}{Figure 8}{Figure 9}
The energy deposition of secondary protons is broader out-of-field with respect to other fragments because protons scatter more due to their smaller mass. Furthermore, the secondary
proton beam generated by 16 O is slightly broader than 12 C at the position 60 mm and 62 mm. The relative energy deposition for 16 O is higher than 12 C. With an increase of mass,
the heavier fragments scatter less and mostly in the forward direction of the incident beam. In the case of secondary Li-ions, the lateral dose distribution for both oxygen and carbon ion
are also similar at plateau, at Bragg peak and beyond the Bragg peak. The relative energy deposition for 16 O is also higher than 12 C.

Conclusions

This work compared the energy deposition in a water phantom, produced by oxygen ions, proposed as alternative to carbon ions for hadron therapy. The results show that oxygen beams
are characterized by a higher dose per incident ion and a slightly bigger peak-to-entrance ratio with respect to clinical carbon-ion beams.
With respect to carbon ions, oxygen beams are characterized by higher production of nuclear fragments, which deposit energy beyond the Bragg peak and out-of-field. In addition, such
nuclear fragments have an impact on the RBE. These factors have to be carefully taken into account when considering oxygen ions as a possible alternative to carbon therapy.
This work confirms the results of Kumar et al., who investigated various types of ion species using simulation methods and concluded that oxygen ions are the most suitable heavy ions
for hadron therapy in addition to carbon ions due to a higher peak-to-entrance ratio and higher energy deposition at the Bragg peak, even though it has a slightly higher entrance dose
compared to carbon ion beams.[22]
In the study of the dependence of the RBE on LET by Francesco et al. using research treatment planning system, the results show the RBE of oxygen was 1.68 and 2.83 at the entrance
and at the Bragg peak, respectively and the RBE of carbon was 1.44 and 2.61 at the entrance and at the Bragg peak, respectively. The RBE of oxygen ions is slightly higher than carbon
ions at the entrance and at the Bragg peak.[12] This may be due to the fact that oxygen ions, carrying higher charge, have comparatively higher LET than carbon ions and hence deposit
higher dose from fragmentations, translating into higher RBE for oxygen ions than that for carbon ions. Therefore, oxygen beams may be more efficient than carbon ions with hypoxic
tumors.[10],[11],[12]
Usually, LET is a key parameter to explain the biological effects induced by charged particles. However, the LET depth-dose profile is also influenced by the types of ions, and hence LET
alone cannot explain the differences in their clinical properties. The RBE depends on many parameters, such as LET, fractionation, oxygenation, cell cycle, and endpoint. This study
focused on the physical properties of carbon and oxygen ion beams, but biological aspects should be considered as well so that the choice of the optimal ion depends on the specific
tumor configuration.[23],[24]
Future experimental works will be carried out at the HIMAC, NIRS. Other ions lighter than carbon ions will be studied, especially helium, as helium nuclei are expected to have favorable
dose distributions and a high potential for application in hadron therapy.[25],[26]
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